他汀类药物、新发阿尔茨海默病、认知功能变化及神经病理学 - Suppr

Suppr

超能文献

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.

作者信息

Pappolla Miguel A

出版信息

Neurology. 2008 Dec 9;71(24):2020; author reply 2020-1.

PMID:19086266

Abstract

摘要

相似文献

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.

Neurology. 2008 Dec 9;71(24):2020; author reply 2020-1.

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.

Neurology. 2008 Jul 29;71(5):383; author reply 383. doi: 10.1212/01.wnl.0000324089.63164.16.

Does statin use decrease the amount of Alzheimer disease pathology in the brain?

Neurology. 2007 Aug 28;69(9):E8-11. doi: 10.1212/01.wnl.0000280585.95661.1b.

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.

Neurology. 2008 Dec 9;71(24):2019; author reply 2019-20. doi: 10.1212/01.wnl.0000342450.63664.f5.

Isoprenoids and Alzheimer's disease: a complex relationship.

Neurobiol Dis. 2006 May;22(2):209-22. doi: 10.1016/j.nbd.2005.11.007. Epub 2006 Jan 10.

Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins.

Psychiatr Danub. 2008 Jun;20(2):162-7.

Statins: drugs for Alzheimer's disease?

J Neural Transm (Vienna). 2005 Aug;112(8):1057-71. doi: 10.1007/s00702-004-0273-1. Epub 2005 Jan 31.

Total cholesterol levels and the risk of mild cognitive impairment and Alzheimer's disease.

J Am Geriatr Soc. 2007 Jan;55(1):133-5. doi: 10.1111/j.1532-5415.2006.01003.x.

Nature or nurture: education and the trajectory of declining brain function with age and Alzheimer disease.

Neurology. 2008 May 6;70(19 Pt 2):1725-7. doi: 10.1212/01.wnl.0000311452.58110.c7.

Statins: true wonder drugs?

Johns Hopkins Med Lett Health After 50. 2002 Jul;14(5):1-2, 7.

引用本文的文献

Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer's Disease.

Biomedicines. 2021 Dec 14;9(12):1910. doi: 10.3390/biomedicines9121910.

Therapeutic interventions targeting Beta amyloid pathogenesis in an aging dog model.

Curr Neuropharmacol. 2011 Dec;9(4):651-61. doi: 10.2174/157015911798376217.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.

Neurology. 2008 Dec 9;71(24):2020; author reply 2020-1.

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.

Neurology. 2008 Jul 29;71(5):383; author reply 383. doi: 10.1212/01.wnl.0000324089.63164.16.

Does statin use decrease the amount of Alzheimer disease pathology in the brain?

Neurology. 2007 Aug 28;69(9):E8-11. doi: 10.1212/01.wnl.0000280585.95661.1b.

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.

Neurology. 2008 Dec 9;71(24):2019; author reply 2019-20. doi: 10.1212/01.wnl.0000342450.63664.f5.

Isoprenoids and Alzheimer's disease: a complex relationship.

Neurobiol Dis. 2006 May;22(2):209-22. doi: 10.1016/j.nbd.2005.11.007. Epub 2006 Jan 10.

Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins.

Psychiatr Danub. 2008 Jun;20(2):162-7.

Statins: drugs for Alzheimer's disease?

J Neural Transm (Vienna). 2005 Aug;112(8):1057-71. doi: 10.1007/s00702-004-0273-1. Epub 2005 Jan 31.

Total cholesterol levels and the risk of mild cognitive impairment and Alzheimer's disease.

J Am Geriatr Soc. 2007 Jan;55(1):133-5. doi: 10.1111/j.1532-5415.2006.01003.x.

Nature or nurture: education and the trajectory of declining brain function with age and Alzheimer disease.

Neurology. 2008 May 6;70(19 Pt 2):1725-7. doi: 10.1212/01.wnl.0000311452.58110.c7.

Statins: true wonder drugs?

Johns Hopkins Med Lett Health After 50. 2002 Jul;14(5):1-2, 7.

引用本文的文献

Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer's Disease.

Biomedicines. 2021 Dec 14;9(12):1910. doi: 10.3390/biomedicines9121910.

Therapeutic interventions targeting Beta amyloid pathogenesis in an aging dog model.

Curr Neuropharmacol. 2011 Dec;9(4):651-61. doi: 10.2174/157015911798376217.